BioSpace News Archive

Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) Board of Directors announces the appointment of Hector Bremner as Chief Executive Officer and Bob Rai as President effective immediately.

Today, Johnson & Johnson Innovation – JLABS (JLABS) and Janssen Research & Development, LLC, in collaboration with the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response in the U.S. Department of Health and Human Services

KelseyCare Advantage is among an elite group of plans to have achieved a 5-out-of-5 star rating four years in a row, the highest possible rating for service and quality by CMS

U.S. News & World Report, the global authority in healthcare rankings, released the 2020 Best Insurance Companies for Medicare Advantage and Prescription Drug Plans.

Codexis, Inc. (Nasdaq: CDXS), a leading protein engineering company, assembled approximately 150 top scientists in protein engineering to discuss recent progress and future direction in a forum held last week in Palo Alto, Calif.

BMO Insurance Financial Hardship Life Advance offered to those in financial difficulty and who have a life expectancy of five years or less

SOUTH SAN FRANCISCO, Calif., Oct. 15, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, will showcase innovative RNA sequencing applications using microfluidics technology at the American Society of Human Genetics (ASHG) annual meeting in Houston, Texas, from October 15 to 19. “As the demand for RNA NGS sequencing continues to rise, many genomics laboratories have found i

Vapotherm, Inc. (NYSE: VAPO) (“Vapotherm”), a global medical technology company focused on the development and commercialization of its proprietary Hi-VNI® Technology products that are used to treat patients of all ages suffering from respiratory distress, announced today that it will release financial results for the third quarter of 2019 after the close of trading on Tuesday, November 5, 2019

Conformis, Inc. (NASDAQ: CFMS) announced today that it will host a webcast on Wednesday, October 30, 2019, at 4:30 p.m. Eastern Time to discuss its financial results for the third quarter ended September 30, 2019.

Tactical Medical Solutions, LLC (“TacMed”), a leading innovator and manufacturer of proprietary pre-hospital medical components and technology for tactical and civilian applications, and Guardian Capital Partners, announce the acquisition of TraumaFX Solutions, Inc. (“TFX”).